Skip to Main Content

Paper Details

Real-world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure-response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study.
Aliment Pharmacol Ther
12
2022
Author NameAffiliation
William J SandbornUniversity of California San Diego School of Medicine
Parambir S DulaiMedical College of Wisconsin
  • 1 - 2

Datasets

Release 1.2